iShares Nasdaq Biotechnology Index Fund ETF News

Fifth Third Securities Inc. acquired a new position in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund acquired 2,864 shares of the financial services providers stock, valued at approximately $463,000. Other hedge funds and other institutional investors have []

If there's an asset class that's looking forward to 2022, it's small- and mid-cap (SMID) biotechnology stocks because that group dealt with a variety of headwinds this year. However, there are more re

Take a look at some top-ranked ETFs that might help strengthen your portfolio and rake in some good returns.

Greg Zuckerman, special writer at the Wall Street Journal, joins the 'Halftime Report' to discuss why Moderna and Pfizer's underperformance in the markets are causing hedge funds to lose money.

Although the Healthcare sector is having a positive year in absolute terms, that isn't the case in relative terms.

White Lighthouse Investment Management Inc. reduced its position in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 1.5% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 12,654 shares of the financial services providers stock after selling 197 shares during the quarter. White Lighthouse []

Arkadios Wealth Advisors trimmed its holdings in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 15.2% during the third quarter, HoldingsChannel.com reports. The fund owned 4,759 shares of the financial services providers stock after selling 850 shares during the period. Arkadios Wealth Advisors holdings in iShares Nasdaq Biotechnology ETF were worth $769,000 as of its most recent []

Stratos Wealth Partners LTD. cut its position in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 0.5% in the third quarter, Holdings Channel reports. The institutional investor owned 18,334 shares of the financial services providers stock after selling 87 shares during the period. Stratos Wealth Partners LTD.s holdings in iShares Nasdaq Biotechnology ETF were worth []

Fifth Third Bancorp raised its holdings in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 0.2% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 42,024 shares of the financial services providers stock after buying an additional 85 shares during the quarter. Fifth Third Bancorp []

BBH: Better Than IBB For Covid Exposure Including The Omicron Variant

GRAND RAPIDS, Mich. and WALL, N.J., Nov. 30, 2021 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), today announced Grand Rapids Community College (GRCC) has selected its PortalGuard IAM solution to provide its users with strong authentication security and seamless access to mission-critical applications and data at its campuses located throughout western Michigan.

Private Advisor Group LLC grew its position in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 17.0% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 45,887 shares of the financial services providers stock after buying an additional 6,660 shares during the quarter. Private []

Moderna (NasdaqGS: MRNA) jumped on Monday after announcing that a higher dosage booster of its vaccine could help mitigate COVID-19 Omicron risks before a tailor-made shot is finalized, lifting biotechnology sector-related exchange traded funds. On Monday, the Invesco Nasdaq Biotechnology ETF (IBBQ) rose 1.4% and iShares Biotechnology ETF (IBB) gained 1.7%. Moderna shares climbed 11.8% [] The post Modernas Omicron Booster Strategy Lifts Biotechnology ETFs appeared first on ETF Trends .

Moderna (NasdaqGS: MRNA) jumped on Monday after announcing that a higher dosage booster of its vaccine could help mitigate COVID-19 Omicron risks before a tailor-made shot is finalized, lifting biotec

Winfield Associates Inc. decreased its position in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 1.2% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 25,040 shares of the financial services provider’s stock after selling 310 shares during the period. iShares Nasdaq Biotechnology ETF comprises about 1.5% of Winfield […]